PubMed چکیده/رکورد

Survival After Hematopoietic Stem Cell Transplantation in Diamond-Blackfan Anemia Syndrome: The Role of Iron Overload-A Systematic Review.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

We assessed the effect of iron overload (IO) on mortality and complications following hematopoietic stem cell transplantation (HSCT) in patients with Diamond-Blackfan anemia syndrome (DBAS) in a systematic review of individual participant data and cohort data from observational studies. PubMed and EMBASE were searched up to 24 November 2025. Eligible studies included English or Dutch observational studies of pediatric or adult patients with confirmed DBAS undergoing HSCT, with documented transfusion history and sufficient follow-up. Abstract-only and congress publications were excluded. The search identified 993 records, of which 42 studies comprising 443 patients were included. Mortality related to IO was inconsistently reported. When reported, infections (31 cases) and graft-versus-host disease (18 cases) were the most frequent causes of death. IO assessment varied substantially, with heterogeneous diagnostic criteria and measurement methods. Although it has been demonstrated that IO affects patient outcomes in DBAS, the available evidence is currently insufficient to determine its direct association with mortality after HSCT specifically. Risk of bias assessment using ROBINS-E indicated high risk of bias, mainly due to exposure measurement and missing data, resulting in very low certainty of evidence. The effect of IO on HSCT outcomes in DBAS cannot be determined due to heterogeneous exposure definitions and methodological limitations. Importantly, the absence of a demonstrable association should not be interpreted as evidence that IO is safe in the transplant setting. Pretransplant IO should therefore be considered a clinically relevant potential risk factor for posttransplant morbidity and mortality, although current DBAS-specific evidence is insufficient to quantify its independent effect on HSCT outcomes. Future studies should incorporate standardized biochemical and imaging-based assessment of iron burden and systematically report iron chelation strategies to improve understanding of its impact on transplant outcomes, particularly in older patients.

متن کامل اصلی

متن در JumpToDate ذخیره نشده است.

برای بررسی دسترسی کتابخانه‌ای یا خرید، رکورد اصلی را باز کنید.

رفتن به منبع اصلی
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2027

Clinical Flow Cytometric Testing in Chronic Lymphocytic Leukemia.

Flow cytometry is the cornerstone for establishing the diagnosis of chronic lymphocytic leukemia (CLL), owing to its characteristic and well-defined immunophenotype that enables accurate distinction from other leukemias and lymphomas. Beyond diagnosis, flow cytometry provides essential prognostic information and allows sensitive detection of minimal residual disease (MRD), a strong predictor of clinical outcome. CLL MRD assessment is i…

PubMed2027

Flow Cytometric Immunophenotyping of Acute Lymphoblastic Leukemia.

Immunophenotyping by flow cytometry is an important component in the diagnostic evaluation of patients with acute lymphoblastic leukemia. This technique further permits the detection of minimal residual disease after therapy, a robust prognostic factor that may guide individualized treatment. We describe here laboratory methods for both the initial characterization of lymphoblasts at diagnosis and the detection of rare leukemic lymphob…

PubMed2027

Immunophenotyping of Acute Myeloid Leukemia.

Immunophenotyping by multiparameter flow cytometry is a rapid and efficient technique to simultaneously assess and correlate multiple individual cell properties like size and internal complexity along with antigen expression in a population of cells. This method is utilized for rapid characterization of the blasts and classification of acute myeloid leukemia (AML) in both the peripheral blood (PB) and bone marrow (BM). This technique i…

PubMed2027

Measurable Residual Disease.

Measurable residual disease (MRD) serves as a critical biomarker of prognosis, treatment efficacy, and clinical outcome. It captures the presence of residual tumor cells below the detection threshold of conventional microscopy. Multiparametric flow cytometry (MFC) offers a rapid, cost-efficient, and widely applicable platform for MRD detection through leukemia-associated immunophenotypes (LAIPs) and deviation-from-normal (DfN) antigen …